A citation-based method for searching scientific literature

Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard. J Clin Oncol 2014
Times Cited: 766



. Nature 2011
Times Cited: 4596




List of shared articles



Times cited

Current status of cancer immunotherapy for gynecologic malignancies.
Hiroshi Nishio, Takashi Iwata, Daisuke Aoki. Jpn J Clin Oncol 2021
2

A source of hope for platinum-resistant ovarian cancer?
Sarah P Blagden, Shibani Nicum. Lancet 2021
1

Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer.
Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming's, Anne Vincent-Salomon, Fatima Mechta-Grigoriou. Sci Rep 2021
2

Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer.
Olivia Le Saux, Hélène Vanacker, Fatma Guermazi, Mélodie Carbonnaux, Clémence Roméo, Louis Larrouquère, Olivier Trédan, Isabelle Ray-Coquard. Future Oncol 2021
0

Creation and validation of models to predict response to primary treatment in serous ovarian cancer.
Jesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, Brian J Smith, David P Bender, Michael J Goodheart, Megan E McDonald, Terry A Braun, Kristina W Thiel, Kimberly K Leslie. Sci Rep 2021
2

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review.
Melissa Bradbury, Eva Borràs, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Anna Santamaria, Eduard Sabidó. Cancers (Basel) 2021
0

Advances in the treatment of platinum resistant epithelial ovarian cancer: an update on standard and experimental therapies.
Shuk On Annie Leung, Panagiotis A Konstantinopoulos. Expert Opin Investig Drugs 2021
0

PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations.
Hélène Vanacker, Philipp Harter, Sana Intidhar Labidi-Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray-Coquard. Cancer Treat Rev 2021
0

Treatment Experience and Predictive Factors Associated with Response in Platinum-Resistant Recurrent Ovarian Cancer: A Retrospective Single-Institution Study.
Radu Dragomir, Ioan Sas, Sorin Săftescu, Dorel Popovici, Roxana Margan, Adelina Silvana Dragomir, Horia Stanca, Valeria Mocanu, Cristina Pac, Șerban Negru. J Clin Med 2021
0

Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.
Claudia Marchetti, Francesca De Felice, Alessia Romito, Valentina Iacobelli, Carolina Maria Sassu, Giacomo Corrado, Caterina Ricci, Giovanni Scambia, Anna Fagotti. Semin Cancer Biol 2021
1

Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer.
Rebecca L Porter, Ursula A Matulonis. J Clin Oncol 2021
0

The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas.
Benoit You, Gilles Freyer, Antonio Gonzalez-Martin, Stephanie Lheureux, Iain McNeish, Richard T Penson, Sandro Pignata, Eric Pujade-Lauraine. Cancer Treat Rev 2021
0

Adjuvant and post-surgical treatment in high-grade epithelial ovarian cancer.
Georgina E Wood, Jonathan A Ledermann. Best Pract Res Clin Obstet Gynaecol 2021
0

Oregovomab: an investigational agent for the treatment of advanced ovarian cancer.
Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Domenica Lorusso, Anna Fagotti, Giovanni Scambia. Expert Opin Investig Drugs 2021
1

Obesity and Energy Substrate Transporters in Ovarian Cancer-Review.
Marta Baczewska, Klaudia Bojczuk, Adrian Kołakowski, Jakub Dobroch, Paweł Guzik, Paweł Knapp. Molecules 2021
0

Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.
Aya Saleh, Ruth Perets. Cancers (Basel) 2021
0